Navigation Links
Advanced targeted therapies effective as first-line treatment for lung cancer
Date:8/1/2009

e West, Room 2001-2005, Level 2.

VANDETANIB PLUS DOCETAXEL VERSUS DOCETAXEL AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A RANDOMIZED, DOUBLE-BLIND PHASE III TRIAL (ZODIAC) (ABSTRACT # C2.2)

Vandetanib is an orally administered medication that targets two receptors already known to play a role in non-small cell lung cancer (NSCLC) epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF). These receptors are targeted separately by other drugs, but vandetanib is the first drug designed to target both.

In previous research, the addition of vandetanib to chemotherapy was shown to prolong the progression-free survival (PFS) and improve response rate in patients with previously treated advanced NSCLC. To expand upon these findings, researchers conducted a phase III study to further evaluate whether vandetanib plus chemotherapy prolonged the PFS of advanced NSCLC patients when compared to chemotherapy alone.

Over two years, 1,391 patients were recruited to participate in the study. Patients were randomized to receive chemotherapy with vandetanib or chemotherapy with the placebo. A statistically significant difference in PFS was seen (HR = 0.79) in favor of vandetanib. The median PFS time was 17.3 weeks in the vandetanib arm versus 14 weeks in the control arm. While there was no statistical difference in overall survival, a significant improvement in objective response rate was observed. Vandetanib treatment was also associated with a statistically significant improvement in symptoms related to the underlying cancer.

"Clearly in a disease as heterogeneous as lung cancer, the need to target multiple pathways has become paramount. This agent, targeting two key pathways critical for non-small cell lung cancer growth and metastasis, is novel and could play a key role," said Roy S. Herbst, M.D., Ph.D., chief of thoracic medical oncology at the University of Texa
'/>"/>

Contact: Liz Wulderk
lwulderk@spectrumscience.com
443-506-1931
International Association for the Study of Lung Cancer
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Smith & Nephew Highlights Advanced Wound Management Progress
2. Patient safety advanced by revised heparin standards
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. Penile Prosthesis Surgery Infection Rates Reduced With The No-Touch Technique By Dr. J. Francois Eid of Advanced Urological Care
5. Leading Independent Analyst Firm States Silver Creek Systems Holds A Virtual Monopoly In Delivering Advanced Product Data Quality Capabilities
6. Surgery remans an option for advanced lung cancer
7. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
8. Hendrick Health System Deploys Sentillions Tap & Go Advanced Authentication Solution
9. Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
10. Marienkrankenhaus Hamburg Installs Visage(R) CS Enterprise Wide Advanced Visualization Solutions
11. Advanced Bag Design for Cryopreservation: The New CryoMACS(R) Freezing Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2
... DALLAS, Feb. 19 Cholesterol-lowering statins, used by ... may falsely indicate thyroid problems, according to researchers ... studies, low serum TSH, and the influence of ... ."These findings could help physicians make quicker, more ...
... experts say , , THURSDAY, Feb. 19 (HealthDay News) -- A ... people with type 2 diabetes, according to a study that ... sites in Canada and the United States. , The participants, ... in diabetes, underwent cognitive tests designed to measure several aspects ...
... EAST PROVIDENCE, R.I., Feb. 19 IlluminOss ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today ... Bone Stabilization System had been performed on a 21 ... metacarpal.With traditional methods of treating fractures, often an incision ...
... Association and nation,s largest animal protection group say taxing ... for pet owners, increased pet abandonment and public health ... California Veterinary Medical Association (CVMA) and The Humane Society ... the California Legislature for responding to the public,s opposition ...
... Kovalic & Timothy Ogata Join Leading Private Telemedicine ... Call, Inc. (SOC) a leading private telemedicine company ... has completed the expansion of its senior management ... fastest growing provider of telemedical consultations to hospital ...
... a Champion for BabiesNEW YORK, Feb. 19 The March of ... MVP, Eli Manning , will return for a second year, ... Manning will be joined by CBS 2 News Co-Anchor, Maurice ... , who will co-host the morning program. "I,m very excited to ...
Cached Medicine News:Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:Out-of-Control Blood Sugar May Affect Memory 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 3Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 2Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 3Health News:Specialists On Call Expands Senior Management & Sales Teams 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July 28, ... it has appointed Roger Crystal , MD as ... served in the Global Business Development Product Acquisition & ... "Roger,s experience in developing business strategy and partnerships in ... we continue to partner with biotechnology and pharmaceutical companies ...
(Date:7/28/2014)... 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ... its second quarter and year-to-date 2014 financial results on ... U.S. financial markets. The earnings press release will be ... website, www.anipharmaceuticals.com . Arthur S. ... Charlotte C. Arnold , Vice President and Chief Financial ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... AdvaMed 2011: The MedTech Conference -- day ... Abbott, Abiomed, B. Braun Medical, Baxter International Inc., ... MIT MEDRC in Innovation Alley, a showcase of ... sector meet-ups focused on orthopedic, wound management and ...
... 2011 Tengion, Inc. (Nasdaq: TNGN ) today ... its Board of Directors. Mr. Flora brings to Tengion more ... healing and surgical device businesses.  He most recently served as ... Tengion also announced today that Gary Kurtzman, M.D., ...
Cached Medicine Technology:AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses 2Tengion Appoints Scott Flora to Board of Directors 2Tengion Appoints Scott Flora to Board of Directors 3Tengion Appoints Scott Flora to Board of Directors 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: